更多栏目
搜索
103
文章数
81654
浏览数
储旻华

热衷收罗医药圈从研发到上市的各种“八卦”,然后基于事实和数据加以分析

China Regulations Tracker: Feb 2021
储旻华 · 2021-04-15
China's Fourth Batchs of VBP Sees Massive Drug Price Reductions
Further information
PharmaDJ
China Biotech Fundraising Tracker: Feb 2021
储旻华 · 2021-04-08
Clover Raises Over $400 Million USD, Hopes to Release New COVID-19 Vaccine This Year.
Further information
PharmaDJ
China Licensing Deals Tracker: Feb 2021
储旻华 · 2021-04-04
Junshi, Coherus Sign Deal Bringing New Cancer Drug to North America.
Further information
PharmaDJ
依从性提高 多公司角力长效生长激素 | 江湖
储旻华 · 2021-03-31
国内仅有1款长效制剂上市,7款处在临床开发阶段。
Further information
江湖
China Market Approval Tracker: Feb 2021
储旻华 · 2021-03-29
Six NMEs Get Market Approval in China.
Further information
PharmaDJ
Kintor‘s Cancer Drug Reduces COVID-19 Mortality R...
储旻华 · 2021-03-22
Its nonsteroidal antiandrogen candidate proxalutamide reduced mortality risk by 92% and shortened the median length of hospital stays by nine days, according to an investigator-initiated trial conducted in Brazil.
Further information
PharmaDJ
China Biotech Fundraising Tracker: Jan 2021
储旻华 · 2021-03-03
Together, 18 of them reported deals that totaled more than $683 million USD. Two companies raised over $100 million USD alone: VISEN Pharmaceuticals and Abbisko Therapeutics.
Further information
PharmaDJ
China Regulations Tracker: Jan 2021
储旻华 · 2021-03-03
Biosimiars will be included in VBP.
Further information
PharmaDJ
China Licensing Deals Tracker: Jan 2021
储旻华 · 2021-02-19
China's biopharmaceutical industry completed a dozen licensing deals in the first month of 2021, continuing its 2020 trend of cross-the-border hot licensing deals.
Further information
PharmaDJ
China Market Approval Tracker: Jan 2021
储旻华 · 2021-02-19
Takeda、Beigene、Antengene
Further information
PharmaDJ
加载更多

个人信息

电子邮箱

chu.minhua@pharmadj.com

公司

研发客

职位

研究院院长

Copyright © 2016-2020 研发客.All Rights Reserved.
建议反馈: Support@PharmaDJ.com
备案/许可证编号: 沪ICP备17054709号-1
联系电话:021 - 88194359